浓缩腹膜液回输治疗腹水——210例患者318次操作的回顾
Treatment of ascites by reinfusion of concentrated peritoneal fluid--review of 318 procedures in 210 patients.
作者信息
Lévy V G, Opolon P, Pauleau N, Caroli J
出版信息
Postgrad Med J. 1975 Aug;51(598):564-6. doi: 10.1136/pgmj.51.598.564.
Abstract
A modified plate dialyser (Rhône-Poulenc) was used 318 times to concentrate ascites for reinfusion in 210 patients, most of them having longstanding ascites refractory to diuretic treatment. The advantages of this method of treatment are its rapidity and efficacy, ascites being reduced in a mean time of 21±13 hr. Hyponatraemia is easily corrected by a sodium load during reinfusion. There was improvement in renal function in 11 of 37 cases. Adverse effects are fever, pulmonary oedema, peritoneal infections and coagulation disorders. Ascites recurred in 84% of the cases, but the procedure shortens hospital stay and reduces the cost of the treatment.
摘要
一种改良平板透析器（罗纳 - 普朗克公司生产）被用于210例患者的腹水浓缩回输，共使用318次，其中大多数患者有长期顽固性腹水，利尿剂治疗无效。这种治疗方法的优点是快速有效，腹水平均在21±13小时内减少。回输过程中通过补充钠可轻松纠正低钠血症。37例中有11例肾功能得到改善。不良反应包括发热、肺水肿、腹膜感染和凝血障碍。84%的病例腹水复发，但该操作缩短了住院时间并降低了治疗成本。
相似文献
1
Treatment of ascites by reinfusion of concentrated peritoneal fluid--review of 318 procedures in 210 patients.浓缩腹膜液回输治疗腹水——210例患者318次操作的回顾
Postgrad Med J. 1975 Aug;51(598):564-6. doi: 10.1136/pgmj.51.598.564.
2
Treatment of resistant ascites by continuous ultrafiltration--reinfusion of ascitic fluid.持续超滤-腹水回输治疗顽固性腹水
Can Med Assoc J. 1977 Dec 3;117(11):1296-8.
3
Concentration-reinfusion (CR) of ascitic of ascitic fluid in the treatment of decompensated liver cirrhosis with diuretic-resistant ascites.腹水浓缩回输（CR）治疗利尿剂抵抗性腹水的失代偿期肝硬化
Postgrad Med J. 1975 Aug;51(598):577-80. doi: 10.1136/pgmj.51.598.577.
4
[Treatment of ascites with reinfusion of ascitic fluid concentrate].[腹水浓缩回输治疗腹水]
Bratisl Lek Listy. 2000;101(5):306-9.
5
Treatment of intractable ascites by continuous reinfusion of the sterilized, cell-free and concentrated ascitic fluid.通过持续回输无菌、无细胞且浓缩的腹水来治疗顽固性腹水。
Trans Am Soc Artif Intern Organs. 1977;23:699-702.
6
[The reinfusion of ascitic fluid into patients with liver cirrhosis and ascites resistant to drug treatment].
Vutr Boles. 1989;28(4):93-6.
7
[A simple method for the reinfusion of ascitic fluid in hemodialysis patients].[一种用于血液透析患者腹水回输的简单方法]
Z Urol Nephrol. 1981 Jul;74(7):497-500.
8
[Extracorporeal dialysis and ultrafiltration of ascitic fluid plus reinfusion: a therapeutic alternative for resistant ascites].
Rev Med Chil. 1987 Jan;115(1):47-55.
9
Ascites reinfusion using Rhodiascit apparatus--clinical experience and coagulation abnormalities.使用罗地亚腹水回输装置进行腹水回输——临床经验与凝血异常
Postgrad Med J. 1975 Aug;51(598):583-7. doi: 10.1136/pgmj.51.598.583.
10
Concentrated ascitic fluid reinfusion after cascade filtration in tense ascites.
Dig Dis Sci. 1993 May;38(5):903-8. doi: 10.1007/BF01295918.
引用本文的文献
1
Fibrinolysis in Dogs with Intracavitary Effusion: A Review.犬胸腔积液中的纤维蛋白溶解：综述
Animals (Basel). 2022 Sep 20;12(19):2487. doi: 10.3390/ani12192487.
2
Do Nutritional Interventions Improve the Outcomes of Patients with Cirrhosis and Ascites: A Systematic Review of Randomized Trials.营养干预能否改善肝硬化腹水患者的预后：随机试验的系统评价
Curr Hepatol Rep. 2020 Jun;19(2):71-77. doi: 10.1007/s11901-020-00513-1. Epub 2020 Apr 22.
3
Enhanced fibrinolysis detection in a natural occurring canine model with intracavitary effusions: Comparison and degree of agreement between thromboelastometry and FDPs, D-dimer and fibrinogen concentrations.腔内积液的自然发生犬模型中增强的纤维蛋白溶解检测：血栓弹力描记术与 FDPs、D-二聚体和纤维蛋白原浓度的比较和一致性程度。
PLoS One. 2019 Nov 14;14(11):e0225089. doi: 10.1371/journal.pone.0225089. eCollection 2019.
4
Hemostatic findings of pleural fluid in dogs and the association between pleural effusions and primary hyperfibrino(geno)lysis: A cohort study of 99 dogs.犬胸腔积液的止血检查结果及胸腔积液与原发性高纤维蛋白（原）溶解之间的关联：一项对99只犬的队列研究
PLoS One. 2018 Feb 20;13(2):e0192371. doi: 10.1371/journal.pone.0192371. eCollection 2018.
5
Hemostatic Findings in Ascitic Fluid: A Cross-Sectional Study in 70 Dogs.腹水的止血研究结果：70只犬的横断面研究
J Vet Intern Med. 2017 Jan;31(1):43-50. doi: 10.1111/jvim.14610. Epub 2016 Nov 16.
6
Reinfusion of ascites during hemodialysis as a treatment of massive refractory ascites and acute renal failure.血液透析期间腹水回输治疗大量难治性腹水和急性肾衰竭
Int J Nephrol Renovasc Dis. 2011;4:29-33. doi: 10.2147/IJNRD.S15792. Epub 2011 Feb 2.
7
Fibrinolytic activity of ascites caused by alcoholic cirrhosis and peritoneal malignancy.酒精性肝硬化和腹膜恶性肿瘤所致腹水的纤溶活性
Gut. 1993 Aug;34(8):1120-2. doi: 10.1136/gut.34.8.1120.
8
Renin-angiotensin-aldosterone system in cirrhosis.肝硬化中的肾素-血管紧张素-醛固酮系统
Gut. 1980 Jun;21(6):545-54. doi: 10.1136/gut.21.6.545.
9
Antithrombin III metabolism in patients with liver disease.肝病患者的抗凝血酶III代谢
J Clin Pathol. 1984 May;37(5):523-30. doi: 10.1136/jcp.37.5.523.
10
Morbidity and mortality after peritoneovenous shunt surgery for refractory ascites.顽固性腹水行腹腔静脉分流术后的发病率和死亡率。
Gut. 1985 Oct;26(10):1070-3. doi: 10.1136/gut.26.10.1070.
本文引用的文献
1
[Drying of cirrhotic ascites by continuous intravenous reinjection of concentrated ascitic fluid].[通过持续静脉再注射浓缩腹水来干燥肝硬化腹水]
Ann Med Interne (Paris). 1971 Nov;122(11):1075-85.
2
[Coagulation disorders after reinjection of concentrated ascitic fluid. Preliminary study].[浓缩腹水回注后的凝血功能障碍。初步研究]
Med Chir Dig. 1973;2(5):275-80.
Zotero 插件